Expert Analysis

Md. Ruling Reflects Classic Administrative Law Principle

A Maryland federal court's recent decision in Columbus v. Kennedy significantly limits how far the Centers for Med... (more story)

Healthcare Orgs Should Prep For Greater Grant Oversight

The U.S. Department of Health and Human Services' new Audit Enforcement and Risk Oversight initiative, and a propo... (more story)

Key Tips For Patenting Antibody-Drug Conjugate Inventions

Recent decisions highlight the significant challenges that can arise when patenting antibody-drug conjugates, whic... (more story)

Deals & Corporate Governance More

Ipsen Buying Memo Therapeutics For Up To $800M

French drugmaker Ipsen said Wednesday it has agreed to acquire Swiss biotechnology company Memo Therapeutics AG in a deal that could be worth more than €700 million ($796.6 million), expanding its pipeline of ... (more story)

Healthcare Deals This Week: Merck, Novartis And More

It was deal after deal this past week, as Big Pharma continued to scoop up companies.

Health Attys Talk Cooperation In Gov't Fraud Investigations

For attorneys defending healthcare clients hit with grand jury subpoenas and other enforcement actions investigating potential cases of fraud, cooperation with federal prosecutors is key.

Zenas Wins Dismissal Of IPO Suit Over R&D Spending Claims

A Massachusetts federal judge has permanently dismissed an investor suit alleging Zenas BioPharma hid how quickly it was spending money before its 2024 initial public offering, saying the company warned invest... (more story)

UCHealth Workers Fight Bid To Toss Wage Suit

Two former hospital workers urged a Colorado federal court to keep alive their proposed class and collective action alleging University of Colorado Health shorted hourly employees through a time-rounding polic... (more story)

Insulin Makers Can't Nix 340B Antitrust Claims On Remand

A New York federal judge trimmed proposed class action claims by providers alleging Sanofi-Aventis and other drugmakers colluded to deny them discounts on insulin products under the 340B program, allowing most... (more story)

Digital Health & Technology More

Patients Say Colo. Health Network Didn't Secure HIV Data

A Colorado healthcare organization that operates as the state's largest source of services and programs for people impacted by HIV did not protect patients' private information in a cyberattack, according to t... (more story)

Meta Fails To Knock Out BIPA Voiceprint Privacy Claims

A California federal judge has refused to let Meta Platforms Inc. escape an Illinois woman's proposed class claims that Meta collects "voiceprints" in violation of Illinois' Biometric Information Privacy Act, ... (more story)

Steps For Employers After 7th Circ. BIPA Retroactivity Ruling

The Seventh Circuit's recent ruling in Clay v. Union Pacific sharply limits per-scan statutory damages theories in pending Biometric Information Privacy Act cases by retroactively applying a 2024 amendment, bu... (more story)

Planned Parenthood Sent Patient Data To Google, Suit Says

Planned Parenthood and regional affiliates were hit with a proposed class action alleging they use hidden tracking tools on their website and patient portals to transmit sensitive sexual and reproductive healt... (more story)

Stryker Says Data Breach Suit Built On Speculation

Michigan-based medical technology company Stryker Corp. has asked a federal judge to toss a proposed class action over a March cyberattack, arguing the former and current employees suing the company cannot sho... (more story)

Wellstar Reaches Deal In Patient Data-Sharing Suit

Georgia's largest healthcare system has reached a settlement with a group of anonymous patients who alleged that the confidential health information of "millions" was shared with Meta Platform Inc. without con... (more story)

Policy & Compliance More

Alibaba Cos. Ink $600M Nonprosecution Deal Over Drug Sales

Alibaba Group Holding Ltd. and its U.S.-based payment processor AUS Merchant Services Inc. will avoid prosecution and pay $600 million to end the U.S. Department of Justice's allegations that they allowed merc... (more story)

Big Pharma Cos. Want 340B Drug Price FCA Suit Tossed

Four major pharmaceutical companies Wednesday urged a California federal court to toss False Claims Act allegations revived by the Ninth Circuit claiming they filed false ceiling prices for drugs and overcharg... (more story)

three women and a man sit onstage for a panel discussion
Gov't Officials Tout Unprecedented Healthcare Fraud Push

It's been an unprecedented year for healthcare fraud enforcement, senior government officials from the U.S. Justice Department and Department of Health and Human Services told conference attendees gathered in ... (more story)

Amgen Wins Order Blocking Colorado's Enbrel Price Cap

Colorado is preliminarily blocked from enforcing its price cap on Amgen's rheumatoid arthritis drug Enbrel, a federal judge ruled Wednesday, saying the biotech company is likely to succeed on its claim that fe... (more story)

8th Circ. Keeps Missouri's 340B Contract Pharmacy Law Alive

The Eighth Circuit declined Wednesday to temporarily block a Missouri law that bars drugmakers from imposing restrictions on federally funded providers that contract with pharmacies to distribute discount drug... (more story)

AIDS Group Says Cigna-Owned Express Scripts Hurts Patients

AIDS Healthcare Foundation says its nonprofit wellness centers are going to be run out of business if Cigna-owned pharmacy benefit manager Express Scripts isn't stopped from using its muscle in the market to s... (more story)

What To Know As Sen. Cassidy Proposes Changes To 340B

Newly introduced Senate legislation could radically change the scope of the 340B drug discount program, including by altering how providers tap discounts and provider deals with pharmacies.